- Home
- LSCC vs RVMD Comparison
LSCC vs RVMD Comparison
Compare LSCC & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSCC
- RVMD
- Stock Information
- Founded
- LSCC 1983
- RVMD 2014
- Country
- LSCC United States
- RVMD United States
- Employees
- LSCC N/A
- RVMD N/A
- Industry
- LSCC Semiconductors
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LSCC Technology
- RVMD Health Care
- Exchange
- LSCC Nasdaq
- RVMD Nasdaq
- Market Cap
- LSCC 8.0B
- RVMD 8.7B
- IPO Year
- LSCC 1989
- RVMD 2020
- Fundamental
- Price
- LSCC $59.66
- RVMD $45.29
- Analyst Decision
- LSCC Strong Buy
- RVMD Strong Buy
- Analyst Count
- LSCC 12
- RVMD 12
- Target Price
- LSCC $62.83
- RVMD $64.67
- AVG Volume (30 Days)
- LSCC 2.0M
- RVMD 2.0M
- Earning Date
- LSCC 02-10-2025
- RVMD 02-24-2025
- Dividend Yield
- LSCC N/A
- RVMD N/A
- EPS Growth
- LSCC N/A
- RVMD N/A
- EPS
- LSCC 1.02
- RVMD N/A
- Revenue
- LSCC $562,578,000.00
- RVMD $742,000.00
- Revenue This Year
- LSCC N/A
- RVMD N/A
- Revenue Next Year
- LSCC $3.07
- RVMD $1,855.42
- P/E Ratio
- LSCC $58.23
- RVMD N/A
- Revenue Growth
- LSCC N/A
- RVMD N/A
- 52 Week Low
- LSCC $40.65
- RVMD $25.93
- 52 Week High
- LSCC $85.69
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- LSCC 53.98
- RVMD 38.74
- Support Level
- LSCC $57.20
- RVMD $42.53
- Resistance Level
- LSCC $64.69
- RVMD $44.22
- Average True Range (ATR)
- LSCC 2.64
- RVMD 1.55
- MACD
- LSCC -0.37
- RVMD -0.07
- Stochastic Oscillator
- LSCC 32.84
- RVMD 43.26
About LSCC Lattice Semiconductor Corporation
Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.